How to Establish a Pharmaceutical Wholesale and Distribution Company

Pharmaceutical distribution is regulated at several levels at once. The EDE describes itself as the only federal authority responsible for regulating all medical and pharmaceutical products. Its listed services include drug approval and registration, market authorisation, pharmacovigilance, and control and inspection.

Below that sits the emirate. The Department of Economic Development issues the commercial licence and the trade name reservation, and Civil Defence certifies fire safety. The Ministry of Health and Prevention (MOHAP) licenses the pharmacists. Confirm which licence category applies to your model before you sign a lease, because the EDE's primary inspection asks for a municipality-approved site layout plan and a tenancy contract.

Then there is the commercial registrar, which has the least to say. A company registered with a medical-trading activity but no licensed warehouse behind it cannot hold stock, and no manufacturer will appoint it. The EDE's final approval asks for the commercial licence only after the inspections, so the entity comes late in the design. Ask whether your premises, people and quality system can pass assessment, since that decides when trading begins.

The same physical box of medicine can carry different duties for different parties. Decide which of these you are:

Groups often split along these lines: one entity with the physical warehouse, another holding the manufacturer relationships. That works only if every product has one clearly accountable holder for registration, storage and safety reporting. Manufacturers and regulators both look for gaps in that map. Calling the business logistics, a trading platform or market-access consulting does not take it outside the regime if it takes custody of medicines or holds their registrations.

Product registration and market authorisation sit with the EDE, so a distributor needs to know early who holds each registration. A distribution agreement does not automatically give you registration rights, and manufacturers differ on whether they register through you or through another party. Settle this in the term sheet, not after the first shipment arrives.

Pharmacovigilance is a standing duty, not a launch task. Someone must receive adverse-event reports and complaints, pass them on, and run a recall if one is called. Name that person before you apply.

Controlled medicines carry further conditions. Confirm with the EDE and the emirate authority whether any product in your portfolio falls into a controlled category, because that changes permits, storage security and record-keeping for the whole warehouse.

Write the result as a licensing map: premises standard, roles and who fills them, product categories and any controlled lines, and the storage and transport standards the chain must meet. That one document serves as the application plan, the hiring plan and the pitch to manufacturers. Whether you set up under a mainland company or a free-zone entity (see free zone or mainland), the health authority's assessment is the same gate.

The EDE publishes its warehouse fees: an application fee of AED 100, AED 1,000 for each primary inspection, AED 1,000 for each final inspection, and a final licence fee of AED 7,500 for a Medical Warehouse or AED 10,000 for a Warehouse for Re-Export. Beside a temperature-controlled, monitored warehouse and the licensed pharmacists you must employ, these are small, and the warehouse and staff recur every year. Product registrations add cost in proportion to portfolio size. Ask every adviser to separate authority fees from premises, payroll, insurance and their own charges. Velarozone's own fee is itemised in the engagement letter (see how Velarozone works).

Banks and manufacturers read a distributor as a licensing story. The asset is an assessed establishment, named professionals and a working quality system. Have these ready before onboarding: the product and manufacturer portfolio, the responsible-professional plan, your distribution and storage procedures, warehouse qualification records, and recall and adverse-event arrangements. Manufacturers often audit harder than banks, visiting the warehouse, interviewing staff and testing the recall procedure before granting territory. A file where the licence scope, the staffing and the facility describe one operation passes both reviews faster. Bank preparation is covered in corporate bank account readiness.

The costliest pattern is sequencing by convenience instead of licensing logic. Compare routes by their whole path: establishment, professionals, products, renewals. A company that is quick to incorporate but slow to staff is not ahead.

Premises and professionals must exist before the establishment can be assessed, the establishment before products register, and products before trading. The EDE states 3 working days per phase, provided a complete application is submitted, so most delay comes from incomplete files and the other entities involved. Incorporation is the quickest milestone and the least informative.

Renewals recur on several clocks: the establishment, each professional, each product registration, warehouse requalification and calibration, and safety reporting. Visas for clinical-grade staff follow once the roles are agreed. If your plan includes unusual ownership above the licensed entity, see regulated and complex ownership setup.